Montelukast Prescribing at GLADSTONE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
449
Total Quantity
18.4K
NHS Cost
£872
vs National Avg
-34.4%
GLADSTONE HOUSE SURGERY prescribed 449 items of Montelukast over the last 12 months at a cost of £872 to the NHS. This is 34.4% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
39
Jun 2026
35
Jun 2026
38
Jun 2026
38
Jun 2026
36
Jun 2026
39
Jun 2026
34
Jun 2026
43
Jun 2026
42
Jun 2026
36
Jun 2026
36
Jun 2026
33
Prescribing Details
| Total Items | 449 |
|---|---|
| Total Quantity | 18,396 |
| Total NHS Cost | £872 |
| Presentations | 4 different forms |
| vs National Average | -34.4% |
Montelukast Prescribing Comparison
| This practice | 449 items |
|---|---|
| National average per practice | 685 items |
| Difference | -34.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.